Wall Street Signals: Marijuana Company of America Announces the Relaunch of Its Reformulated Patent Pending CBD Product hempSMART™ Brain

Marijuana Company of America Announces the Relaunch of Its Reformulated Patent Pending CBD Product hempSMART™ Brain

MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC:MCOA), an inventive hemp and cannabis organization, is satisfied to report that the Company's hempSMART™ image has relaunched its lead wellbeing item hempSMART™ Brain with 10mg of Cannabidiol (CBD) oil per serving. 

hempSMART Brain has been relaunched and upgraded with an enhanced definition that incorporates 300mg for every container of Full Spectrum, non-psychoactive, water dissolvable CBD oil per serving and contains a herbal mix of all-regular plant-based fixings, for example, Ashwaganda, Fulvic Acid, Rhodiola Rosea Extract, Bacopa, L-Theanine, Green Tea Extract, and Huperzia Serrata. 

hempSMART Brain has been created to keep up mental clearness, sharpness, center and focus and in addition advance unwinding, helpful rest, and bolster the repair and recovery of mind cells, also called neurogenesis. This remarkable recipe guarantees to change the sheltered, successful, and characteristic improvement of cerebrum health. 

MCOA's CEO Donald Steinberg expressed, "In the wake of assessing our hempSMART Brain item, our formulators enhanced the first item by multiplying the first measurement of CBD. Our group is pleased to have the capacity to welcome our lead item back onto the market and anticipate the up and coming showcasing efforts."

About Marijuana Company of America, Inc.

MCOA is an organization which takes part in: (1) item innovative work of lawful hemp-based buyer items under the brand name "hempSMART™", that objectives general wellbeing and prosperity; (2) an offshoot showcasing system to advance and offer its lawful hemp-based customer items containing CBD; (3) renting of genuine property to isolate business substances occupied with the development and offer of cannabis in those states and wards where cannabis has been legitimized and legitimately managed for therapeutic and amusements utilize; and, (4) the extension of its business into subordinate territories of the sanctioned cannabis and hemp industry, as the authorized markets and openings in this fragment develop and create.

About Our hempSMART™ Products Containing CBD

The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication, and disclaims CBD as a dietary supplement. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition.

Forward Looking Statements

This news discharge contains "forward-looking proclamations" which are not simply verifiable and may incorporate any announcements with respect to convictions, plans, desires or expectations in regards to what's to come. Such forward-looking explanations incorporate, in addition to other things, the improvement, expenses and consequences of new business openings and words, for example, "foresee", "look for", expect", "trust", "appraise", "expect", "venture", "design", or comparable expressions might be regarded "forward-looking proclamations" inside the significance of the Private Securities Litigation Reform Act of 1995. Genuine outcomes could contrast from those anticipated in any forward-looking explanations because of various elements. Such factors incorporate, among others, the characteristic vulnerabilities related with new tasks, the future U.S. furthermore, worldwide economies, the effect of rivalry, and the Company's dependence on existing controls in regards to the utilization and advancement of cannabis-based items. These forward-looking proclamations are made as of the date of this news discharge, and we accept no commitment to refresh the forward-looking articulations, or to refresh the reasons why genuine outcomes could vary from those anticipated in the forward-looking explanations. Despite the fact that we trust that any convictions, plans, desires and aims contained in this official statement are sensible, there can be no confirmation that any such convictions, plans, desires or expectations will turn out to be exact. Speculators ought to counsel the greater part of the data put forward in this and ought to likewise allude to the hazard factors exposure sketched out in our yearly cover Form 10-12G, our quarterly reports on Form 10-Q and other occasional reports documented every once in a while with the Securities and Exchange Commission.

For more data, please visit www.sec.gov

please visit the Company’s websites